ClinicalTrials.gg
Not yet recruitingNCT07719816QUALIPEPSYUpdated Aug 5, 2026

Qualitative Study of Student Financial Insecurity and Psychiatry

An observational study in Depressive Disorder, Generalized Anxiety Disorder and Suicidal Ideation, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.

Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.

The aim of the study is to explore the lived experiences of the students concerned in order to identify what they perceive as the various aspects of student precarity (housing, transport, isolation, financial difficulties, etc.) and the links they perceive between these and their psychological distress. This study will deepen our understanding of these factors by exploring students' lived experiences, and will bring to light elements not identified by quantitative studies.

Read the detailed description

The COVID-19 pandemic has led to an increase in depression, particularly among young people. The French health barometer, conducted every 4-5 years by Santé Publique France (SPF), found that the prevalence of major depressive episodes (MDE) among 18-25 year olds doubled (from 11.7% to 20.8%) between 2017 and 2021. There has also been an increase in suicidal thoughts and suicide attempts. Among students, data from the 2016 Student Life Observatory (OVE) found a higher prevalence of CDE and suicidal thoughts among students than in the general population of the same age. Among the factors associated with the risk of EDC, experiencing significant financial difficulties was the main one[4]. Among medical students, a national study conducted in 2021 found that the prevalence of depression and suicidal thoughts was much higher than in the general population of the same age. Financial difficulties were also the main factor associated with the risk of depression. Indeed, students are a population that is particularly vulnerable to precariousness due to several factors. Economically, they often have limited incomes, depending on parental support, insufficient grants or precarious jobs. This exposes them to difficulties in meeting their basic needs such as housing, food and healthcare. Socially, isolation can exacerbate their situation, especially when they are far from their family network or under pressure from their studies. In addition, high academic demands, combined with unstable living conditions, impact their mental health and can contribute to the development of psychiatric disorders, which often go untreated due to a lack of affordable and accessible resources. International students are even more vulnerable due to language and administrative barriers and limited access to local support services. This multidimensional precariousness highlights the need for comprehensive support for this population, even though students are unlikely to seek professional help. In the 2021 survey, only 32% of medical students suffering from depression received adequate care. If we want to improve the health of medical students, we must not only treat disorders, but also prevent them from occurring by helping students strive for a state of well-being. In terms of prevention, the Haute Autorité de Santé (HAS) distinguishes between three levels: primary prevention, which acts upstream of the disease (on risk factors); secondary prevention, which acts at an early stage of its development (screening); and tertiary prevention, which acts on complications and the risk of recurrence.

02

Conditions studied

  • Depressive Disorder
  • Generalized Anxiety Disorder
  • Suicidal Ideation

Keywords

  • Students
  • Depression
  • Use of care
  • Qualitative study
  • Precarity
03

In context

Depressive Disorder

855 studies on the registry are indexed under Depressive Disorder; 159 are open to participants now.

This study's planned enrollment of 30 is below the median of 174 across 140 observational studies indexed under Depressive Disorder.

Browse Depressive Disorder studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Student enrolled at Paris Sciences et Lettres (PSL) University or the Faculty of Health Sciences at Université Paris Cité (UPC)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A student enrolled at Paris Sciences et Lettres (PSL) University or the Faculty of Health Sciences at Université Paris Cité (UPC),
  • Aged 18 or over,
  • Fluent in French,
  • be a student,
  • have used the PPOP scheme,
  • not object to participating after receiving clear information.

Exclusion criteria

Exclusion Criteria:

  • Participants under the age of 18,
  • not enrolled at PSL universities or the UPCS Faculty of Health Sciences,
  • insufficient proficiency in French to conduct an interview,
  • refusal to participate,
  • clinical vulnerability deemed incompatible by the referring consultant.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients

    Students

    Other: Semi-structured interviews

Interventions

  • OtherSemi-structured interviews

    Semi-structured interviews

06

What researchers measure

Primary outcomes

  1. Semi-structured interview

    This is an exploratory, inductive qualitative study. The aim is not to measure but to explore and understand these students' lived experiences, without any preconceived assumptions

    Time frame: Day of inclusion

Secondary outcomes

  1. Semi-structured interview

    This is an exploratory, inductive qualitative study. The aim is not to measure but to explore and understand these students' lived experiences, without any preconceived assumptions

    Time frame: Day of inclusion

07

Study locations

1 site
  • Adult Psychiatry Department - Hôtel-Dieu Hospital
    Paris, IDF 75014, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07719816
Collaborators
URC-CIC Paris Descartes Necker Cochin, Fondation hospitalière pour la recherche sur la précarité et l'exclusion sociale, Institut National de la Santé Et de la Recherche Médicale, France
Responsible party
Sponsor
First posted
Jul 22, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Aug 5, 2026

Study contacts

Cédric LEMOGNE, MC, PhD
Contact
cedric.lemogne@aphp.fr
0033 1 42 34 85 76
Marie BENHAMMANI-GODARD
Contact
marie.godard@aphp.fr
0033158411190
Ariel FRAJERMAN, MD
study chair · Institut National de la Santé Et de la Recherche Médicale, France
Jordan SIBEONI, MD, PhD
study director · Institut National de la Santé Et de la Recherche Médicale, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion